Cargando…
Chromogranin A: From Laboratory to Clinical Aspects of Patients with Neuroendocrine Tumors
Background. Neuroendocrine tumors (NETs) are characterized by having behavior and prognosis that depend upon tumor histology, primary site, staging, and proliferative index. The symptoms associated with carcinoid syndrome and vasoactive intestinal peptide tumors are treated with octreotide acetate....
Autores principales: | Di Giacinto, Paola, Rota, Francesca, Rizza, Laura, Campana, Davide, Isidori, Andrea, Lania, Andrea, Lenzi, Andrea, Zuppi, Paolo, Baldelli, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051263/ https://www.ncbi.nlm.nih.gov/pubmed/30057604 http://dx.doi.org/10.1155/2018/8126087 |
Ejemplares similares
-
Somatostatin Analogs Therapy in Gastroenteropancreatic Neuroendocrine Tumors: Current Aspects and New Perspectives
por: Baldelli, Roberto, et al.
Publicado: (2014) -
Thyroid dysfunction in COVID-19 patients
por: Baldelli, R., et al.
Publicado: (2021) -
Significance of chromogranin A and synaptophysin in pancreatic neuroendocrine tumors
por: Tomita, Tatsuo
Publicado: (2020) -
Limited Diagnostic Utility of Chromogranin A Measurements in Workup of Neuroendocrine Tumors
por: Baekdal, Jonas, et al.
Publicado: (2020) -
Chromogranin A in the Laboratory Diagnosis of Pheochromocytoma and Paraganglioma
por: Bílek, Radovan, et al.
Publicado: (2019)